Recent Finacing
Recent Raise
Quentis Therapeutics is a preclinical biotech developing small-molecule IRE1α inhibitors and additional ER-stress pathway therapies to modulate XBP1 activity in the tumor microenvironment and restore anti-tumor immunity.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Quentis Therapeutics.
